Thrombosis Clinical Trials

33 recruiting

Thrombosis Trials at a Glance

140 actively recruiting trials for thrombosis are listed on ClinicalTrialsFinder across 6 cities in 37 countries. The largest study group is Not Applicable with 34 trials, with the heaviest enrollment activity in Beijing, Cleveland, and New York. Lead sponsors running thrombosis studies include Kafrelsheikh University, Ottawa Hospital Research Institute, and Xuanwu Hospital, Beijing.

Browse thrombosis trials by phase

Treatments under study

About Thrombosis Clinical Trials

Looking for clinical trials for Thrombosis? There are currently 33 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new Thrombosis trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about Thrombosis clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 120 of 140 trials

Recruiting

Cleaner Long-tErm Assessment Registry - Venous Insights and Efficacy With eXtended Tracking

Deep Vein Thrombosis (DVT)Venous EmbolismThrombus in the Peripheral Venous Vasculature+1 more
Argon Medical Devices185 enrolled3 locationsNCT07102160
Recruiting

Freiburg TIPS Registry

Liver CirrhosisPortal Vein ThrombosisPortal Hypertension+3 more
University Hospital Freiburg2,000 enrolled1 locationNCT05782556
Recruiting
Not Applicable

DEFIANCE: RCT of ClotTriever System Versus Anticoagulation In Deep Vein Thrombosis

Deep Venous ThrombosisVenous Thromboembolism
Inari Medical300 enrolled64 locationsNCT05701917
Recruiting

Autopsy and Photon Counting Computed Tomography to Evaluate Thromboses Related to Central Venous Catheters

Central Venous Catheter Thrombosis
Thomas Kander75 enrolled1 locationNCT06417541
Recruiting

Registry of Patients Prescribed Anticoagulation

Acute Pulmonary EmbolismAcute Deep Vein Thrombosis
Mayo Clinic10,000 enrolled1 locationNCT03504007
Recruiting
Not Applicable

Collection of Blood Samples for New Diagnostic Devices 2

InfectionsEmbolism and ThrombosisInflammation+2 more
LumiraDx UK Limited20,000 enrolled7 locationsNCT05568966
Recruiting

ATHNdataset Registry

ThrombosisSickle Cell DiseaseHemophilia A+6 more
American Thrombosis and Hemostasis Network200,000 enrolled1 locationNCT06820515
Recruiting

Platelet Volunteers, Longitudinal and Multi-omic Study

Thrombosis
National Heart, Lung, and Blood Institute (NHLBI)400 enrolled1 locationNCT07137429
Recruiting

Post-Market Celect Platinum Vena Cava Filter and Gunther Tulip Retrieval Set Study

Venous ThromboembolismPulmonary EmbolismDeep Vein Thrombosis
Cook Research Incorporated82 enrolled7 locationsNCT05881798
Recruiting
Early Phase 1

Apixaban in Thrombocytopenia

ThrombocytopeniaDeep Vein ThrombosisPulmonary Embolism and Thrombosis+1 more
Rushad Patell30 enrolled1 locationNCT06886516
Recruiting

Prospective Evaluation of the Treatment of Cancer Associated Superficial Venous

CancerSuperficial Vein Thrombosis
Centre Hospitalier Universitaire, Amiens1,576 enrolled1 locationNCT07210671
Recruiting
Phase 3

REGN7508 in Adult Participants for Prevention of Cancer-Associated Thrombosis

Cancer-Associated Thrombosis (CAT)
Regeneron Pharmaceuticals860 enrolled12 locationsNCT07410117
Recruiting
Phase 3

Efficacy and Safety of Tenecteplase Bridging Mechanical Thrombectomy for Acute Large Vessel Occlusion Stroke

Stroke, IschemicDrug EffectStroke, Acute+1 more
Xuanwu Hospital, Beijing850 enrolled1 locationNCT06658197
Recruiting
Not Applicable

The GORE® VIABAHN® FORTEGRA Venous Stent Iliofemoral Study

Venous UlcerVenous StenosisVenous Occlusion+7 more
W.L.Gore & Associates165 enrolled27 locationsNCT05489588
Recruiting
Phase 2

Neoadjuvant Pembrolizumab and Axitinib in Renal Cell Carcinoma With Inferior Vena Cava Tumor Thrombus

Renal Cell CarcinomaKidney CancerRenal Cancer+1 more
University of Colorado, Denver17 enrolled3 locationsNCT05969496
Recruiting

Multi-Omics-Based Novel Thrombosis and Bleeding Markers and Risk Model for CHD

ThrombosisBleedingCoronary Artery Disease (CAD)
Xueyan Zhao12,154 enrolled3 locationsNCT07523880
Recruiting
Phase 4

Apixaban-PK Trial: Preventing Portal Hypertension Complications in Cirrhosis

CirrhosisAscitesPortal Vein Thrombosis+3 more
Asian Institute Of Medical Sciences220 enrolled1 locationNCT07521332
Recruiting
Not Applicable

Direct Comparison of Cardiac CT With TEE to Evaluate Watchman FLX LAA Occluder Device Characteristics

Device Related ThrombosisPeri-device Leak
University Hospitals Cleveland Medical Center320 enrolled5 locationsNCT06523166
Recruiting

RevCore for In Stent Thrombosis

In-stent Thrombosis
Inari Medical100 enrolled15 locationsNCT06394739
Recruiting
Not Applicable

Efficacy of Apixaban in the Treatment of Portal Vein Thrombosis Occurring More Than One Year After LS

CirrhosisPortal Vein ThrombosisHypertension, Portal+1 more
Northern Jiangsu People's Hospital20 enrolled1 locationNCT07461545